These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 25892718

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
    Donis RO, Influenza Cell Culture Working Group, Davis CT, Foust A, Hossain MJ, Johnson A, Klimov A, Loughlin R, Xu X, Tsai T, Blayer S, Trusheim H, Colegate T, Fox J, Taylor B, Hussain A, Barr I, Baas C, Louwerens J, Geuns E, Lee MS, Venhuizen O, Neumeier E, Ziegler T.
    Vaccine; 2014 Nov 12; 32(48):6583-90. PubMed ID: 24975811
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Tzeng TT, Lai CC, Weng TC, Cyue MH, Tsai SY, Tseng YF, Sung WC, Lee MS, Hu AY.
    Vaccine; 2019 Nov 08; 37(47):7117-7122. PubMed ID: 31383484
    [Abstract] [Full Text] [Related]

  • 8. Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform.
    Chia MY, Lin CY, Chen PL, Lai CC, Weng TC, Sung WC, Hu AY, Lee MS.
    Viruses; 2022 Aug 31; 14(9):. PubMed ID: 36146744
    [Abstract] [Full Text] [Related]

  • 9. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY, Weng TC, Tseng YF, Chen YS, Wu CH, Hsiao S, Chou AH, Chao HJ, Gu A, Wu SC, Chong P, Lee MS.
    Vaccine; 2008 Oct 23; 26(45):5736-40. PubMed ID: 18761387
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
    Huang D, Peng WJ, Ye Q, Liu XP, Zhao L, Fan L, Xia-Hou K, Jia HJ, Luo J, Zhou LT, Li BB, Wang SL, Xu WT, Chen Z, Tan WS.
    PLoS One; 2015 Oct 23; 10(11):e0141686. PubMed ID: 26540170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y, Odagiri T, Tashiro M, Nobusawa E.
    PLoS One; 2016 Oct 23; 11(7):e0160040. PubMed ID: 27454606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH, Kwon HI, Park SJ, Kim YI, Si YJ, Lee IW, Kim SM, Kim SI, Ahn DH, Choi YK.
    J Microbiol Biotechnol; 2018 Jun 28; 28(6):997-1006. PubMed ID: 29642288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.